Sonnet BioTherapeutics (NASDAQ:SONN) Posts Earnings Results
Sonnet BioTherapeutics (NASDAQ:SONN – Get Free Report) posted its earnings results on Tuesday. The company reported ($0.55) earnings per share (EPS) for the quarter, FiscalAI reports. Sonnet BioTherapeutics Price Performance NASDAQ:SONN traded down $2.09 during mid-day trading on Tuesday, reaching $1.02. The stock had a trading volume of 10,084,314 shares, compared to its average volume […]
16 Dec 22:00 · The Markets Daily